Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2119181rdf:typepubmed:Citationlld:pubmed
pubmed-article:2119181lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:2119181lifeskim:mentionsumls-concept:C0023343lld:lifeskim
pubmed-article:2119181lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:2119181lifeskim:mentionsumls-concept:C2754997lld:lifeskim
pubmed-article:2119181lifeskim:mentionsumls-concept:C0020852lld:lifeskim
pubmed-article:2119181pubmed:issue2lld:pubmed
pubmed-article:2119181pubmed:dateCreated1990-10-26lld:pubmed
pubmed-article:2119181pubmed:abstractTextThe distribution of IgG and IgM antibodies immunoreacting with the sulpholipid I (SLI) and sulpholipid IV (SLIV) of Mycobacterium tuberculosis was examined in sera from leprosy patients. It was found that the immunological reactions correlated with the clinical spectrum of leprosy; and in multibacillary patients, antibody titres declined in response to successful treatment. The serological patterns were similar to the PGL I patterns, however, the IgG responses towards the sulpholipids were predominant over the IgM responses in the case of the sulpholipid antigens.lld:pubmed
pubmed-article:2119181pubmed:languageenglld:pubmed
pubmed-article:2119181pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2119181pubmed:citationSubsetIMlld:pubmed
pubmed-article:2119181pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2119181pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2119181pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2119181pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2119181pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2119181pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2119181pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2119181pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2119181pubmed:statusMEDLINElld:pubmed
pubmed-article:2119181pubmed:monthJunlld:pubmed
pubmed-article:2119181pubmed:issn0934-8840lld:pubmed
pubmed-article:2119181pubmed:authorpubmed-author:DavidH LHLlld:pubmed
pubmed-article:2119181pubmed:authorpubmed-author:PapaFFlld:pubmed
pubmed-article:2119181pubmed:authorpubmed-author:CruaudPPlld:pubmed
pubmed-article:2119181pubmed:authorpubmed-author:Orsi-SouzaA...lld:pubmed
pubmed-article:2119181pubmed:authorpubmed-author:Torgal-Garcia...lld:pubmed
pubmed-article:2119181pubmed:authorpubmed-author:PotarM CMClld:pubmed
pubmed-article:2119181pubmed:authorpubmed-author:MarojaFFlld:pubmed
pubmed-article:2119181pubmed:issnTypePrintlld:pubmed
pubmed-article:2119181pubmed:volume273lld:pubmed
pubmed-article:2119181pubmed:ownerNLMlld:pubmed
pubmed-article:2119181pubmed:authorsCompleteYlld:pubmed
pubmed-article:2119181pubmed:pagination209-15lld:pubmed
pubmed-article:2119181pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:2119181pubmed:meshHeadingpubmed-meshheading:2119181-...lld:pubmed
pubmed-article:2119181pubmed:meshHeadingpubmed-meshheading:2119181-...lld:pubmed
pubmed-article:2119181pubmed:meshHeadingpubmed-meshheading:2119181-...lld:pubmed
pubmed-article:2119181pubmed:meshHeadingpubmed-meshheading:2119181-...lld:pubmed
pubmed-article:2119181pubmed:meshHeadingpubmed-meshheading:2119181-...lld:pubmed
pubmed-article:2119181pubmed:meshHeadingpubmed-meshheading:2119181-...lld:pubmed
pubmed-article:2119181pubmed:meshHeadingpubmed-meshheading:2119181-...lld:pubmed
pubmed-article:2119181pubmed:meshHeadingpubmed-meshheading:2119181-...lld:pubmed
pubmed-article:2119181pubmed:meshHeadingpubmed-meshheading:2119181-...lld:pubmed
pubmed-article:2119181pubmed:meshHeadingpubmed-meshheading:2119181-...lld:pubmed
pubmed-article:2119181pubmed:meshHeadingpubmed-meshheading:2119181-...lld:pubmed
pubmed-article:2119181pubmed:meshHeadingpubmed-meshheading:2119181-...lld:pubmed
pubmed-article:2119181pubmed:year1990lld:pubmed
pubmed-article:2119181pubmed:articleTitleIgG and IgM antibodies immunoreacting with a 2,3-diacyl trehalose-2'-sulphate in sera from leprosy patients.lld:pubmed
pubmed-article:2119181pubmed:affiliationUnité de la Tuberculose et des Mycobactéries, Institut Pasteur, Paris, France.lld:pubmed
pubmed-article:2119181pubmed:publicationTypeJournal Articlelld:pubmed